Leukocyte-reduced blood transfusions: Perioperative indications, adverse effects, and cost analysis

Anesthesia and Analgesia

Volumn 90, Issue 6, 2000, Pages 1315-1323

  Sharma, Ajeet D ^a   Sreeram, Gautam ^a,b   Erb, Thomas ^a   Grocott, Hilary P ^a   Slaughter, Thomas F ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; HEALTH CARE COST; HUMAN; LEUKOCYTE; LEUKOCYTE ACTIVATION; PEROPERATIVE CARE; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION;

EID: 0034076812     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200006000-00010     Document Type: Review

References (99)

1. Herzig RH, Herzig GP, Bull MI, et al. Correction of poor platelet transfusion responses with leukocyte-poor HLA-matched platelet concentrates. Blood 1975;46:743-50.
2. Eernisse JG, Brand A. Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components. Exp Hematol 1981;9:77-83.
3. Jensen LS. Benefits of leukocyte-reduced blood transfusions in surgical patients. Curr Opin Hematol 1998;5:376-80.
4. Sweeney JD. Leukoreduction of blood supply in Rhode Island. Med Health/Rhode Island 1998;81:386-91.
5. Widmann FK. Standards for blood banks and transfusion services. Arlington: American Association of Blood Banks, 1991.
6. Meryman HT, Hornblower M. The preparation of red cells depleted of leukocytes: review and evaluation. Transfusion 1986;26:101-6.
7. Snyder EL. Clinical use of white cell-poor blood components. Transfusion 1989;29:568-71.
8. Ciavarella D, Snyder E. Clinical use of blood transfusion devices. Transfus Med Rev 1988;2:95-111.
9. Dzik S. Leukodepletion blood filters: filter design and mechanisms of leukocyte removal. Transfus Med Rev 1993;7:65-77.
10. Anderson KC, Gorgone BC, Wahlers E, et al. Preparation and clinical utility of leukocyte poor apheresis platelets. Transfus Sci 1991;12:163-70.
11. Horowitz B, Bonomo R, Prince AM, et al. Solvent/Detergent-treated plasma: a virus-inactivated substitute for fresh frozen plasma. Blood 1992;79:826-31.
12. Hellstern P, Sachse H, Schwinn H, et al. Manufacture and invitro characterization of a solvent/detergent-treated plasma. Vox Sang 1992;63:178-5.
13. Blajchman MA, Bardossy L, Carmen RA, et al. An animal model of allogeneic donor platelet refractoriness: the effect of the time of leukodepletion. Blood 1992;79:1371-5.
14. Humbert JR, Fermin CD, Winsor EL. Early damage to granulocytes during storage. Semin Hematol 1991;28:10-3.
15. Chambers LA, Kruskall MS, Pacini DG, et al. Febrile reactions after platelet transfusion: the use of single versus multiple donors. Transfusion 1990;30:219-21.
16. Brubaker DB. Clinical significance of white cell antibodies in febrile nonhemolytic transfusion reactions. Transfusion 1990;30: 733-7.
17. Walker RH. Special report: transfusion risks. Am J Clin Pathol 1987;88:374-8.
18. Sirchia G, Rebulla P, Parravicini A, et al. Removal of white cells from red cells by transfusion through a new filter. Transfusion 1990;30:30-3.
19. Kalmin ND, Orrel JE, Villarreal IG. An effective method for the preparation of leukocyte-poor platelets. Transfusion 1987;27: 281-3.
20. Dzik WH. Is the febrile response to transfusion due to donor or recipient cytokine [letter]? Transfusion 1992;32:594.
21. Heddle NM. The efficacy of leukodepletion to improve platelet transfusion response: a critical appraisal of clinical studies. Transfus Med Rev 1994;8:15-28.
22. Legler TJ, Fisher I, Dittmann J, et al. Frequency and causes of refractoriness in multiply transfused patients. Ann Hematol 1997;74:185-9.
23. Schlichter SJ. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusion. N Engl J Med 1997;337:1861-9.
24. Killick SB, Win N, Marsh JC, et al. Pilot study of HLA alloimmunization after transfusion with pre-storage leukocyte-depleted blood products in aplastic anemia. Br J Haematol 1997;97:677-84.
25. Opelz G, Sengar DP, Mickey MR, et al. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973; 5:253-9.
26. Blajchman MA. Immunomodulatory effects of allogeneic blood transfusions: clinical manifestations and mechanisms. Vox Sang 1998;74:315-9.
27. Blumberg N, Heal JM. Effects of transfusion on immune function: cancer recurrence and infection. Arch Pathol Lab Med 1994;118:371-9.
28. Jensen LS, Andersen AJ, Christiansen PM, et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992;79:513-6.
29. Nielsen HJ, Reimert C, Pederson AN, et al. Leukocyte-derived bioactive substances in fresh frozen plasma. Br J Anaesth 1997; 78:548-52.
30. van de Watering LMG, Hermans J, Houbiers JGA, et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery. Circulation 1998;97:562-8.
31. Jensen LS, Andersen A, Fristrup SC, et al. Comparison of one dose versus three doses of prophylactic antibiotics, and the influence of blood transfusion, on infectious complications in acute and elective colorectal surgery. Br J Surg 1990;77:513-8.
32. The Norwegian Gastro-Intestinal Group (NORGAS). Infectious complications after colorectal surgery of the alimentary tract: the influence of peri-operative factors. Curr Med Res Opin 1988;11:149-58.
33. Tartter PI, Driefus RM, Malon AM, et al. Relationship of postoperative septic complications and blood transfusions in patients with Crohn's disease. Am J Surg 1988;155:43-8.
34. Triuzi DJ, Vanek K, Ryan DH, et al. A clinical and immunological study of blood transfusion and postoperative bacterial infection in spinal surgery. Transfusion 1992;32:517-24.
35. Heiss MM, Mempel W, Jauch KW, et al. Beneficial effect of autologous blood transfusion on infectious complications after colorectal surgery. Lancet 1993 342:1328-33.
36. Jensen LS, Kissmeyer-Nielsen P, Wolff B, et al. Randomized comparison of leukocyte-depleted buffy-coat poor blood transfusion and complications after colorectal surgery. Lancet 1996; 348:841-5.
37. Barret BB, Andersen JW, Andersen KC. Strategies for the avoidance of bacterial contamination of blood components. Transfusion 1994;34:432-7.
38. Sazama K. Bacteria in blood for transfusion. Ann Intern Med 1992;116:55-62.
39. Buchholtz DH, AuBuchon JP, Snyder EL, et al. Removal of Yersinia Enterocolitica from AS-1 red cells. Transfusion 1992;32: 667-72.
40. Wenz B, Ciavarella D, Fredundlich L. Effect of prestorage white cell reduction on bacterial growth in platelet concentrates. Transfusion 1993;32:663-6.
41. Gong J, Hogmen CF, Hambraeus A, et al. Transfusion-associated Serratia marcescens infection: studies of mechanism of action. Transfusion 1993;33:802-8.
42. Freedman JJ, Blajchman MA, McCombie N, et al. Can red cross society symposium of leukocyte depletion: report of proceedings. Transfus Med Rev 1994;8:1-14.
43. Gantt CL. Red blood cells for cancer patients [letter]. Lancet 1981;2:363.
44. Nathanson SD, Tilley BC, Schultz L, et al. Perioperative allogeneic blood transfusions: survival in patients with resected carcinomas of the colon and rectum. Arch Surg 1985;120:734-8.
45. Blumberg N, Agarwal MM, Chaung C. Relation between recurrence of cancer of the colon and blood transfusion. BMJ 1985; 290:1037-9.
46. Parrot NR, Lennard TW, Taylor RM, et al. Effect of perioperative blood transfusion on recurrence of colorectal cancer. Br J Surg 1986;73:970-3.
47. Burrows L, Tartter P, Aufes A. Increased recurrence rates in perioperatively transfused colorectal malignancy patients. Cancer Detect Prev 1987;10:361-9.
48. Corman J, Arnoux R, Peloquin A, et al. Perioperative blood transfusions and colorectal cancer outcome. Transplant Proc 1988;20:1128-9.
49. Waymack JP, Moomaw CJ, Popp MB. The effect of perioperative blood transfusions on long-term survival of colon cancer patients. Military Med 1989;154:515-7.
50. Wobbes T, Joosen KH, Kuypers HH, et al. The effect of packed cells and whole blood transfusions on survival after curative resection for colorectal carcinoma. Dis Colon Rectum 1989;32: 743-8.
51. Vamvakas EC, Moore SB. Perioperative blood transfusion and colorectal cancer recurrence: a qualitative statistical overview and meta-analysis. Transfusion 1993;33:754-65.
52. Vamvakas EC. Perioperative blood transfusion and cancer recurrence: meta-analysis for explanation. Transfusion 1995;35: 760-8.
53. Tang R, Wang JY, Chien CRC, et al. The association between perioperative blood transfusion and survival of patients with colorectal cancer. Cancer 1993;72:341-8.
54. Chung M, Steinmetz OK, Gordon PH. Perioperative blood transfusion and outcome after resection for colorectal carcinoma. Br J Surg 1993;80:427-32.
55. Vamvakas EC. Transfusion-associated cancer recurrence and postoperative infection: meta-analysis of randomized, controlled trials. Transfusion 1996;36:175-86.
56. Tartter PI. The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg 1992;216:633-8.
57. Francis DMA. Relationship between blood transfusion and tumor behavior. Br J Surg 1991;78:1420-8.
58. Blajchman MA, Bardossy L, Carmen R. Allogeneic blood transfusion-induced enhancement of tumor growth: two animal models showing amelioration by leukodepletion and passive transfer using spleen transfer. Blood 1993;81:1880-2.
59. Bordin JO, Bardossy L, Blajchman MA. Growth enhancement of established tumors by allogeneic transfusion in experimental animals its amelioration by leukodepletion: the importance of the timing of the leukodepletion. Blood 1994;84:344-8.
60. Andersen KC, Weinstein HJ. Transfusion-associated graft-versus-host disease. N Engl J Med 1990;323:315-21.
61. Rubinstein A, Radl J, Cottier, et al. Unusual combined immunodeficiency syndrome exhibiting kappa-IgD paraproteinemia, residual gut immunity and graft-versus-host reaction after plasma infusion. Acta Paediatr Scand 1973;62:365-72.
62. Moroff G, Leitman SF, Luban NL. Principles of blood irradiation, dose validation, and quality control. Transfusion 1997;37: 1084-92.
63. Dzik WH, Jones KS. The effects of gamma irradiation versus white cell reduction on the mixed lymphocyte reaction. Transfusion 1993;33:493-6.
64. Glenn J. Cytomegalovirus infections following renal transplantation. Rev Infect Dis 1991;3:1151-78.
65. Luban NL, Williams AE, MacDonald MG, et al. Low incidence of acquired cytomegalovirus infection in neonates transfused with washed red blood cells. Am J Dis Child 1987;141:416-9.
66. Bowden RA, Slichter SJ, Sayers M, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995;86: 3598-603.
67. Bowden RA. Cytomegalovirus infections in transplant patients: methods of prevention of primary cytomegalovirus. Transplant Proc 1991;23:136-8.
68. Okochi K, Sato H. Transmission of adult T-cell leukemia virus (HTLV-1) through blood transfusion and its prevention. AIDS Res 1986;2:5157-61.
69. Klein MA, Frigg R, Flechig, et al. A crucial role for B cells in neuroinvasive scarpie. Nature 1997;390:687-98.
70. Andreu G. Early leukocyte depletion of cellular blood components reduces red blood cell and platelet storage lesions. Semin Hematol 1991;3:22-5.
71. Riedner C, Heim MU, Mempel W, et al. Possibility to improve preservation of whole blood by leukocyte-depletion before storage. Vox Sang 1990;59:78-82.
72. Gottschall JL, Johnson VL, Rzad L, et al. Importance of white blood cells in platelet storage. Vox Sang 1984;47:101-7.
73. Fijnheer R, Pietersz RNI, de Korte D, et al. Platelet activation during preparation of platelet concentrates: a comparison of platelet-rich plasma and the buffy coat methods. Transfusion 1990;30:634-8.
74. Sloand EM, Klein HG. The effect of white cells on platelets during storage. Transfusion 1990;30:333-8.
75. Ku DD. Coronary vascular reactivity after acute myocardial infarction. Science 1982;218:576-8.
76. Smith CW. Molecular determinants of neutrophil adhesion. Am J Respir Cell Mol Biol 1990;2:487-9.
77. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985;312:159-63.
78. Stahl GL, Reenstra WR, Frendl G. Complement-mediated loss of endothelium-dependant relaxation of porcine coronary arteries: role of the terminal membrane attack complex. Circ Res 1995; 76:575-83.
79. Byrne JG, Appleyard RF, Lee CC, et al. Controlled reperfusion of the regionally ischemic myocardium with leukocyte-depleted blood reduces stunning, the no-reflow phenomenon, and infarct size. J Thorac Cardiovasc Surg 1992;103:66-72.
80. Breda MA, Drinkwater DJ, Laks H, et al. Prevention of reperfusion injury in the neonatal heart with leukocyte-depleted blood. J Thorac Cardiovasc Surg 1989;97:654-65.
81. Schmidt FE, MacDonald MJ, Murphy CO, et al. Leukocyte depletion of blood cardioplegia attenuates reperfusion injury. Ann Thorac Surg 1996;62:1691-7.
82. Pearl JM, Drinkwater DC Jr, Laks H, et al. Leukocyte-depleted reperfusion of transplanted human hearts prevents ultrastructural evidence of reperfusion. J Surg Res 1992;52:298-308.
83. Milhaljevic T, Tonz M, Pasic M, et al. The dynamics of blood composition changes in leukocyte filtration during cardiopulmonary bypass: preliminary results. Helv Chir Acta 1993;60: 403-6.
84. Solis RT, Goldfinger D, Gibbs MB, et al. Physical characteristics of microaggregates in stored blood. Transfusion 1974;14:538-50.
85. Snyder EL, Hezzey A, Barash PG, Palermo G. Microaggregate blood filtration in patients with compromised pulmonary function. Transfusion 1982;22:21-5.
86. Klapper EB, Goldfinger D. Leukocyte-reduced blood components in transfusion medicine. Clin Lab Med 1992;12:711-21.
87. Eastlund T, McGrath PC, Britten A, et al. Fatal pulmonary transfusion reaction to plasma containing donor HLA antibody. Vox Sang 1989;57:63-6.
88. Seeger W, Schneider U, Kreusler B, et al. Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood 1990;76:1438-44.
89. Jensen LS, Grunnet N, Hanberg-Sorensen F, et al. Cost-effectiveness of blood transfusion and white cell reduction in elective colorectal surgery. Transfusion 1985;35:719-22.
90. Lane AL, Andersen KC, Goodough, et al. Leukocyte reduction in blood component therapy. Ann Intern Med 1992;117:151-62.
91. Balducci L, Benson K, Lyman GH, et al. Cost-effectiveness of white-cell reduction filters in treatment of adult acute myelogenous leukemia. Transfusion 1993;33:665-9.
92. Sniecinski I. Clinical application of leukocyte depletion. In Sekiguchi S, ed. Proceedings of the 3rd Hokkaido Symposium. Cambridge: Blackwell Scientific Publications, 1993:202-11.
93. Gott JP, Cooper WA, Schmidt FE, et al. Modifying risk for extracorporeal circulation: trial of four antiinflammatory strategies. Ann Thorac Surg 1998;66:747-54.
94. Abe H, Ikebuchi K, Shisbo M, et al. Hypotension reactions with a white cell-reduction filter: activation of kallikrenin-kinin cascade in a patient [letter]. Transfusion 1998;38:411-2.
95. Shiba M, Tadokoro K, Sawanobori M, et al. Activation of the contact system by filtration of platelet concentrates with a negatively charged white cell-removal filter and measurement of venous blood bradykinin level in patients who received filtered platelets. Transfusion 1997;37:457-62.
96. Mair B, Leparc GF. Hypotensive reactions associated with platelet transfusions and angiotension-converting enzyme inhibitors. Vox Sang 1998;74:27-30.
97. Zoon KC, Jacobsen ED, Woodcock J. Hypotension and bedside leukocyte-reduction filters: letters to Industry/Healthcare Providers. Rockville, MD: U.S. Food and Drug Administration Center for Biologics Evaluation and Research, 1999.
98. Haley NR, Sledge LS, Feller IT, et al. Post transfusion "red eye" syndrome: discovery, investigation, and control [abstract]. Transfusion 1998;38:77A.
99. DV Devine, AJ Bradley, Maurer E, et al. Effects of prestorage white cell reduction on platelet aggregate formation and the activation state of platelets and plasma enzyme systems. Transfusion 1999;39:724-34.